What are the best treatments for Tourette Syndrome?

Treatment for Tourette Syndrome is highly individualized, focusing on reducing the impact of tics on daily life rather than eliminating them entirely. First-line approaches often include Comprehensive Behavioral Intervention for Tics (CBIT), while pharmacological options like alpha-2 adrenergic agonists or antipsychotics are utilized when symptoms significantly interfere with functioning.

What are the first-line treatments for Tourette Syndrome?

For many patients, particularly children, the initial recommended treatment for Tourette Syndrome is Behavioral Therapy. Specifically, Comprehensive Behavioral Intervention for Tics (CBIT) is the gold standard. CBIT teaches patients to identify the premonitory urge—the physical sensation preceding a tic—and to perform a "competing response" that makes the tic difficult or impossible to execute. This approach helps individuals with Tourette Syndrome gain a sense of agency over their symptoms without the side effects associated with medication.

Which medications are commonly used for Tourette Syndrome?

When tics cause social, academic, or physical distress, a physician may prescribe medication. Treatment is always personalized, and no single drug works for every patient. Common classes include:

• Alpha-2 Adrenergic Agonists: Often considered first-line for mild-to-moderate tics, these include clonidine (Catapres) and guanfacine (Tenex, Intuniv).


• Antipsychotics: These are effective for more severe Tourette Syndrome symptoms and may include aripiprazole (Abilify), risperidone (Risperdal), or haloperidol (Haldol).


• VMAT2 Inhibitors: Medications like deutetrabenazine (Austedo) and valbenazine (Ingrezza) are increasingly used to manage involuntary movements.

What are the non-pharmacological and emerging treatments?

Beyond behavioral therapy, other supportive interventions are vital for managing the complex needs of those with Tourette Syndrome. For treatment-refractory cases where tics are debilitating, Deep Brain Stimulation (DBS) is an emerging surgical option that involves implanting electrodes in specific brain regions to regulate neural activity. Furthermore, occupational therapy is frequently recommended to assist with sensory processing issues or fine motor challenges that often co-occur with Tourette Syndrome. Ongoing clinical trials are also investigating the role of cannabinoids, neuromodulation, and specialized diet protocols, though these are not yet considered standard care.

How is a multidisciplinary care team structured?

Because Tourette Syndrome often presents with co-occurring conditions like ADHD, OCD, and anxiety, a multidisciplinary team is essential for comprehensive management. A typical care team might include:

1. A Movement Disorder Specialist or Child Neurologist: To oversee diagnosis and medication management.


2. A Clinical Psychologist/CBIT-certified Therapist: To provide essential behavioral interventions.


3. A Psychiatrist: To address co-occurring mental health conditions that affect nearly 85% of people with Tourette Syndrome.


4. School Counselors or Educational Specialists: To ensure accommodations are in place for learning environments.

Next steps

• Consult a neurologist or psychiatrist specializing in movement disorders to create a personalized treatment plan.


• Seek out a therapist specifically certified in CBIT to help manage tic-related urges.


• Connect with the 387 members of the DiseaseMaps.org community to share experiences and find local support resources.


• Monitor side effects closely when starting new medications and report them to your physician immediately.

Medical disclaimer: This content is for informational purposes only and does not constitute medical advice; please consult with your healthcare provider for diagnosis and treatment decisions specific to your health needs.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Tourette Syndrome.


• Tourette Association of America: Treatment Guidelines and Behavioral Therapy.


• Orphanet: Tourette Syndrome (ORPHA: 3374).


• PubMed/NCBI: Clinical practice guidelines for the management of Tourette syndrome and other tic disorders.